CMPX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Compass Therapeutics Inc (CMPX).


$199.50M Market Cap.

As of 02/27/2025 5:00 PM ET (MRY) • Disclaimer

CMPX Market Cap. (MRY)


CMPX Shares Outstanding (MRY)


CMPX Assets (MRY)


Total Assets

$140.40M

Total Liabilities

$15.17M

Total Investments

$83.24M

CMPX Income (MRY)


Revenue

$850.00K

Net Income

-$49.38M

Operating Expense

$57.48M

CMPX Cash Flow (MRY)


CF Operations

-$44.85M

CF Investing

$46.77M

CF Financing

$17.34M

CMPX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

CMPX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$140,403,000 (-10.50%)

$156,875,000 (-21.42%)

$199,645,000 (29.84%)

$153,757,000 (196.19%)

Assets Current

$132,751,000 (-13.73%)

$153,881,000 (-21.00%)

$194,791,000 (32.42%)

$147,105,000 (193.03%)

Assets Non-Current

$7,652,000 (155.58%)

$2,994,000 (-38.32%)

$4,854,000 (-27.03%)

$6,652,000 (289.23%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$125,233,000 (-15.69%)

$148,538,000 (-18.22%)

$181,638,000 (29.67%)

$140,078,000 (250.68%)

Property Plant & Equipment Net

$7,084,000 (164.92%)

$2,674,000 (-41.02%)

$4,534,000 (-28.40%)

$6,332,000 (462.34%)

Cash & Equivalents

$43,483,000 (79.47%)

$24,228,000 (-30.67%)

$34,946,000 (-75.82%)

$144,514,000 (205.27%)

Accumulated Other Comprehensive Income

$210,000 (467.57%)

$37,000 (112.25%)

-$302,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$83,239,000 (-35.09%)

$128,233,000 (-15.45%)

$151,663,000 (0%)

$0 (0%)

Investments Current

$83,239,000 (-35.09%)

$128,233,000 (-15.45%)

$151,663,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,249,000 (-45.01%)

$4,090,000 (20.93%)

$3,382,000 (290.08%)

$867,000 (-18.28%)

Accumulated Retained Earnings (Deficit)

-$364,683,000 (-15.66%)

-$315,308,000 (-15.58%)

-$272,814,000 (-16.79%)

-$233,589,000 (-54.28%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$6,634,000 (282.80%)

$1,733,000 (-40.95%)

$2,935,000 (-27.30%)

$4,037,000 (-56.75%)

Debt Current

$338,000 (-71.76%)

$1,197,000 (9.12%)

$1,097,000 (10.92%)

$989,000 (-86.76%)

Debt Non-Current

$6,296,000 (1074.63%)

$536,000 (-70.84%)

$1,838,000 (-39.70%)

$3,048,000 (63.26%)

Total Liabilities

$15,170,000 (81.96%)

$8,337,000 (-53.70%)

$18,007,000 (31.64%)

$13,679,000 (14.32%)

Liabilities Current

$8,874,000 (13.75%)

$7,801,000 (-51.75%)

$16,169,000 (52.09%)

$10,631,000 (5.27%)

Liabilities Non-Current

$6,296,000 (1074.63%)

$536,000 (-70.84%)

$1,838,000 (-39.70%)

$3,048,000 (63.26%)

CMPX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$850,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$15,133,000 (23.61%)

$12,243,000 (5.02%)

$11,658,000 (6.69%)

$10,927,000 (-15.35%)

Research & Development Expense

$42,342,000 (11.08%)

$38,120,000 (27.08%)

$29,997,000 (-57.72%)

$70,955,000 (376.08%)

Operating Expenses

$57,475,000 (14.12%)

$50,363,000 (20.91%)

$41,655,000 (-49.13%)

$81,882,000 (177.87%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$49,375,000 (-16.19%)

-$42,494,000 (-8.33%)

-$39,225,000 (52.27%)

-$82,181,000 (-178.58%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$49,375,000 (-16.19%)

-$42,494,000 (-8.33%)

-$39,225,000 (52.27%)

-$82,181,000 (-178.58%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$49,375,000 (-16.19%)

-$42,494,000 (-8.33%)

-$39,225,000 (52.27%)

-$82,181,000 (-178.58%)

Weighted Average Shares

$137,384,000 (8.15%)

$127,027,000 (20.76%)

$105,186,000 (67.31%)

$62,870,000 (104.28%)

Weighted Average Shares Diluted

$137,384,000 (8.15%)

$127,027,000 (20.76%)

$105,186,000 (67.31%)

$62,870,000 (104.28%)

Earning Before Interest & Taxes (EBIT)

-$49,375,000 (-16.19%)

-$42,494,000 (-8.33%)

-$39,225,000 (52.27%)

-$82,181,000 (-178.88%)

Gross Profit

$850,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$56,625,000 (-12.43%)

-$50,363,000 (-20.91%)

-$41,655,000 (49.13%)

-$81,882,000 (-177.87%)

CMPX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$46,772,000 (73.45%)

$26,965,000 (117.83%)

-$151,200,000 (-8442.37%)

-$1,770,000 (-4757.89%)

Net Cash Flow from Financing

$17,338,000 (490.73%)

$2,935,000 (-96.13%)

$75,757,000 (-36.13%)

$118,611,000 (144.37%)

Net Cash Flow from Operations

-$44,855,000 (-10.43%)

-$40,618,000 (-19.03%)

-$34,125,000 (-73.52%)

-$19,666,000 (26.63%)

Net Cash Flow / Change in Cash & Cash Equivalents

$19,255,000 (279.65%)

-$10,718,000 (90.22%)

-$109,568,000 (-212.75%)

$97,175,000 (346.31%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

-$318,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$46,816,000 (73.42%)

$26,995,000 (117.86%)

-$151,164,000 (0%)

$0 (0%)

Capital Expenditure

-$44,000 (-46.67%)

-$30,000 (16.67%)

-$36,000 (97.52%)

-$1,452,000 (-3921.05%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$9,375,000 (-66.67%)

Issuance (Purchase) of Equity Shares

$18,113,000 (468.16%)

$3,188,000 (-95.82%)

$76,252,000 (-40.55%)

$128,267,000 (112.07%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$8,560,000 (39.87%)

$6,120,000 (14.82%)

$5,330,000 (32.29%)

$4,029,000 (0.32%)

Depreciation Amortization & Accretion

$1,753,000 (-7.25%)

$1,890,000 (-0.74%)

$1,904,000 (17.24%)

$1,624,000 (-32.45%)

CMPX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00%

-

-

-

Profit Margin

-5808.80%

-

-

-

EBITDA Margin

-5602.60%

-

-

-

Return on Average Equity (ROAE)

-34.80% (-33.33%)

-26.10% (7.12%)

-28.10% (80.66%)

-145.30% (-72.77%)

Return on Average Assets (ROAA)

-32.60% (-33.06%)

-24.50% (3.92%)

-25.50% (78.46%)

-118.40% (-83.57%)

Return on Sales (ROS)

-5808.80%

-

-

-

Return on Invested Capital (ROIC)

-41.80% (-38.87%)

-30.10% (29.51%)

-42.70% (95.65%)

-981.40% (-37.18%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-4.03 (14.79%)

-4.73 (65.23%)

-13.6 (-461.78%)

-2.42

Price to Sales Ratio (P/S)

234.36

-

-

-

Price to Book Ratio (P/B)

1.59 (18.97%)

1.34 (-61.69%)

3.5 (57.57%)

2.22

Debt to Equity Ratio (D/E)

0.12 (116.07%)

0.06 (-43.43%)

0.1 (1.02%)

0.1 (-67.33%)

Earnings Per Share (EPS)

-0.36 (-9.09%)

-0.33 (10.81%)

-0.37 (71.76%)

-1.31 (-36.46%)

Sales Per Share (SPS)

0.01 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.33 (-2.19%)

-0.32 (1.54%)

-0.33 (3.27%)

-0.34 (61.38%)

Book Value Per Share (BVPS)

0.91 (-21.98%)

1.17 (-32.31%)

1.73 (-22.49%)

2.23 (71.65%)

Tangible Assets Book Value Per Share (TABVPS)

1.02 (-17.25%)

1.24 (-34.93%)

1.9 (-22.40%)

2.45 (44.99%)

Enterprise Value Over EBIT (EV/EBIT)

-3 (25.00%)

-4 (75.00%)

-16 (-300.00%)

-4

Enterprise Value Over EBITDA (EV/EBITDA)

-3.56 (15.19%)

-4.2 (74.78%)

-16.65 (-357.60%)

-3.64

Asset Turnover

0.01 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

14.96 (-24.16%)

19.73 (63.74%)

12.05 (-12.94%)

13.84 (178.35%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$44,899,000 (-10.46%)

-$40,648,000 (-18.99%)

-$34,161,000 (-61.76%)

-$21,118,000 (21.10%)

Enterprise Value (EV)

$169,580,298 (-0.54%)

$170,495,669 (-72.57%)

$621,481,109 (111.97%)

$293,186,061

Earnings Before Tax (EBT)

-$49,375,000 (-16.19%)

-$42,494,000 (-8.33%)

-$39,225,000 (52.27%)

-$82,181,000 (-178.88%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$47,622,000 (-17.28%)

-$40,604,000 (-8.80%)

-$37,321,000 (53.67%)

-$80,557,000 (-197.65%)

Invested Capital

$94,680,000 (-25.20%)

$126,579,000 (-16.43%)

$151,465,000 (5617.82%)

$2,649,000 (-30.42%)

Working Capital

$123,877,000 (-15.20%)

$146,080,000 (-18.22%)

$178,622,000 (30.88%)

$136,474,000 (240.31%)

Tangible Asset Value

$140,403,000 (-10.50%)

$156,875,000 (-21.42%)

$199,645,000 (29.84%)

$153,757,000 (196.19%)

Market Capitalization

$199,504,298 (0.31%)

$198,878,669 (-68.67%)

$634,743,109 (104.26%)

$310,760,061

Average Equity

$141,698,750 (-13.09%)

$163,033,500 (16.62%)

$139,793,000 (147.08%)

$56,578,000 (61.22%)

Average Assets

$151,576,750 (-12.64%)

$173,517,250 (12.98%)

$153,575,750 (121.19%)

$69,431,500 (51.72%)

Invested Capital Average

$118,062,500 (-16.28%)

$141,014,750 (53.40%)

$91,927,500 (997.84%)

$8,373,500 (103.30%)

Shares

137,589,171 (7.92%)

127,486,326 (1.03%)

126,191,473 (28.73%)

98,031,565 (88.08%)